Prognostic value of preoperative lymphocyte-to-monocyte ratio in oral cancer patients and establishment of a dynamic nomogram.

dynamic nomogram inverse probability of treatment weighting analysis lymphocyte-to-monocyte ratio oral cancer overall survival propensity score-matched analysis

Journal

Oral diseases
ISSN: 1601-0825
Titre abrégé: Oral Dis
Pays: Denmark
ID NLM: 9508565

Informations de publication

Date de publication:
Jul 2021
Historique:
revised: 31 07 2020
received: 24 05 2020
accepted: 24 08 2020
pubmed: 4 9 2020
medline: 16 6 2021
entrez: 4 9 2020
Statut: ppublish

Résumé

To assess the association of preoperative lymphocyte-to-monocyte ratio (LMR) and overall survival (OS) in patients with oral cancer and develop a dynamic nomogram for individualized survival prediction. The prognostic value of LMR was evaluated in a large-scale cohort with 651 postoperative patients with oral cancer between January 2010 and December 2017. Propensity score-matched (PSM) analysis and inverse probability of treatment weighting (IPTW) analysis were performed to further verify the prognostic value of LMR. A dynamic nomogram was then developed based on the LMR and clinicopathological features, and its predictive performance and clinical utility were evaluated. A high LMR was significantly associated with better OS of patients with oral cancer (HR = 0.65; 95% CI = 0.44-0.98). The similar association was also observed in the PSM and IPTW analyses. Moreover, compared with TNM staging system, the dynamic nomogram based on the LMR exhibited more excellent predictive performance (0.72 versus 0.64, p < .001), with calibration curves (1,000 bootstrap resamples) suggesting good match between the actual and predicted probabilities. Decision curve analyses (DCAs) showed a more significant positive net benefit in the practical ranges of threshold probabilities using the dynamic nomogram. Preoperative LMR may serve as an easily accessible and non-invasive prognostic biomarker for predicting the prognosis of patients with oral cancer. A dynamic nomogram based on the LMR may show more convenience in survival prediction for patients with oral cancer. Further future studies are warranted to confirm our findings.

Identifiants

pubmed: 32881142
doi: 10.1111/odi.13629
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1127-1136

Subventions

Organisme : Scientific Research Talents Training Project of Health and Family Planning Health Commission in Fujian Province
ID : 2019-ZQN-68
Organisme : Scientific Research Talents Training Project of Health and Family Planning Health Commission in Fujian Province
ID : 2018-1-71
Organisme : Scientific Research Talents Training Project of Health and Family Planning Health Commission in Fujian Province
ID : 2017-ZQN-57
Organisme : Fujian Natural Science Foundation Program
ID : 2019J01314
Organisme : High-level Talents Research Start-up Project of Fujian Medical University
ID : XRCZX2018001
Organisme : Program for New Century Excellent Talents in Fujian Province
ID : 2018B029
Organisme : Startup Fund for Scientific Research of Fujian Medical University
ID : 2017XQ1011
Organisme : Joint Funds For The Innovation Of Science And Technology Of Fujian Province
ID : 2017Y9103

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Altman, D. G., Lausen, B., Sauerbrei, W., & Schumacher, M. (1994). Dangers of using "Optimal" Cutpoints in the evaluation of prognostic factors. Journal of the National Cancer Institute, 86, 829-835.
Austin, P. C., & Stuart, E. A. (2015). Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Statistics in Medicine, 34, 3661-3679.
Balachandran, V. P., Gonen, M., Smith, J. J., & DeMatteo, R. P. (2015). Nomograms in oncology: More than meets the eye. Lancet Oncology, 16, e173-e180.
Bao, X., Liu, F., Chen, Q., Chen, L., Lin, J., Chen, F., … He, B. (2020). Propensity score analysis exploring the impact of smoking and drinking on the prognosis of patients with oral cancer. Head & Neck, 42, 1837-1847.
Calabrese, R., Jalali, A., Alvarez-Iglesias, A., Roshan, D., & Newell, J. (2019). Visualising statistical models using dynamic nomograms. PLoS One, 14, e0225253.
Camp, R. L., Dolled-Filhart, M., & Rimm, D. L. (2004). X-Tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clinical Cancer Research, 10, 7252-7259.
Chan, J. C., Chan, D. L., Diakos, C. I., Engel, A., Pavlakis, N., Gill, A., & Clarke, S. J. (2017). The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Annals of Surgery, 265, 539-546.
Chanmee, T., Ontong, P., Konno, K., & Itano, N. (2014). Tumor-associated macrophages as major players in the tumor microenvironment. Cancers (Basel), 6, 1670-1690.
Chen, F., Lin, L., Liu, F., Yan, L., Qiu, Y., Wang, J., … He, B. (2019). Three prognostic indexes as predictors of response to adjuvant chemoradiotherapy in patients with oral squamous cell carcinoma after radical surgery: A large-scale prospective study. Head and Neck, 41, 301-308.
Chen, F., Lin, L., Yan, L., Qiu, Y., Cai, L., & He, B. (2017). Preoperative neutrophil-to-lymphocyte ratio predicts the prognosis of oral squamous cell carcinoma: A large-sample prospective study. Journal of Oral and Maxillofacial Surgery, 75, 1275-1282.
Furukawa, K., Kawasaki, G., Naruse, T., & Umeda, M. (2019). Prognostic significance of pretreatment lymphocyte-to-monocyte ratio in patients with tongue cancer. Anticancer Research, 39, 405-412.
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010). Immunity, inflammation, and cancer. Cell, 140, 883-899.
Haukoos, J. S., & Lewis, R. J. (2015). The Propensity Score. JAMA, 314, 1637-1638.
Hoffmann, T. K., Dworacki, G., Tsukihiro, T., Meidenbauer, N., Gooding, W., & Johnson, J. T. (2002). Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clinical Cancer Research, 8, 2553-2562.
Ishizuka, M., Nagata, H., Takagi, K., Iwasaki, Y., Shibuya, N., & Kubota, K. (2016). Clinical significance of the C-reactive protein to albumin ratio for survival after surgery for colorectal cancer. Annals of Surgical Oncology, 23, 900-907.
Jariod-Ferrer, U. M., Arbones-Mainar, J. M., Gavin-Clavero, M. A., Simon-Sanz, M. V., Moral-Saez, I., Cisneros-Gimeno, A. I., & Martinez-Trufero, J. (2019). Are comorbidities associated with overall survival in patients with oral squamous cell carcinoma? Journal of Oral and Maxillofacial Surgery, 77, 1906-1914.
Koh, Y. W., Shin, S. J., Park, C., Yoon, D. H., Suh, C., & Huh, J. (2014). Absolute monocyte count predicts overall survival in mantle cell lymphomas: Correlation with tumour-associated macrophages. Hematological Oncology, 32, 178-186.
Lin, J. X., Lin, J. P., Xie, J. W., Wang, J. B., Lu, J., & Chen, Q. Y. (2019). Prognostic value and association of sarcopenia and systemic inflammation for patients with gastric cancer following radical gastrectomy. Oncologist, 24, e1091-e1101.
Moik, F., Zochbauer-Muller, S., Posch, F., Pabinger, I., & Ay, C. (2020). Systemic inflammation and activation of haemostasis predict poor prognosis and response to chemotherapy in patients with advanced lung cancer. Cancers, 12, 1619.
Neyeloff, J. L., Fuchs, S. C., & Moreira, L. B. (2012). Meta-analyses and Forest plots using a microsoft excel spreadsheet: Step-by-step guide focusing on descriptive data analysis. BMC Research Notes, 5, 52.
Nishijima, T. F., Muss, H. B., Shachar, S. S., Tamura, K., & Takamatsu, Y. (2015). Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis. Cancer Treatment Reviews, 41, 971-978.
Ong, H. S., Gokavarapu, S., Wang, L. Z., Tian, Z., & Zhang, C. P. (2017). Low pretreatment lymphocyte-monocyte ratio and high platelet-lymphocyte ratio indicate poor cancer outcome in early tongue cancer. Journal of Oral and Maxillofacial Surgery, 75, 1762-1774.
Ray-Coquard, I., Cropet, C., Van Glabbeke, M., Sebban, C., Le Cesne, A., Judson, I., … Treatment of Cancer Soft T and Bone Sarcoma G, (2009). Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Research, 69, 5383-5391.
Shah, J. P., & Gil, Z. (2009). Current concepts in management of oral cancer-surgery. Oral Oncology, 45, 394-401.
Siegel, R. L., Miller, K. D., & Jemal, A. (2020). Cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7-30.
Sridharan, S., Thompson, L. D., Purgina, B., Sturgis, C. D., Shah, A. A., & Burkey, B. (2019). Early squamous cell carcinoma of the oral tongue with histologically benign lymph nodes: a model predicting local control and vetting of the Eighth Edition of the American Joint Committee on cancer pathologic T stage. Cancer, 125, 3198-3207.
Steidl, C., Lee, T., Shah, S. P., Farinha, P., Han, G., & Nayar, T. (2010). Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. New England Journal of Medicine, 362, 875-885.
Stotz, M., Pichler, M., Absenger, G., Szkandera, J., Arminger, F., Schaberl-Moser, R., … Gerger, A. (2014). The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. British Journal of Cancer, 110, 435-440.
Xu, C., Chen, Y. P., Liu, X., Li, W. F., Chen, L., Mao, Y. P., … Ma, J. (2017). Establishing and applying nomograms based on the 8th edition of the UICC/AJCC staging system to select patients with nasopharyngeal carcinoma who benefit from induction chemotherapy plus concurrent chemoradiotherapy. Oral Oncology, 69, 99-107.
Yan, L., Chen, F., Chen, L., Lin, J., Chen, Q., Bao, X., … Shi, B. (2020). Dynamic evaluation of conditional survival in patients with oral squamous cell carcinoma after surgical resection: A large-scale prospective study. Oral Oncology, 104, 104639.
Zikos, T. A., Donnenberg, A. D., Landreneau, R. J., Luketich, J. D., & Donnenberg, V. S. (2011). Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer. Cancer Immunology, Immunotherapy, 60, 819-827.

Auteurs

Lin Chen (L)

Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fujian, China.
Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Jiawen Qian (J)

Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fujian, China.
Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Lisong Lin (L)

Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

Jing Lin (J)

Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fujian, China.
Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Qing Chen (Q)

Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fujian, China.
Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Zhaocheng Zhuang (Z)

Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fujian, China.
Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Yihong Hong (Y)

Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fujian, China.
Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Jing Wang (J)

Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fujian, China.
Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Yu Qiu (Y)

Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

Lizhen Pan (L)

Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

Bin Shi (B)

Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

Jing Wang (J)

Laboratory Center, School of Public Health, The Major Subject of Environment and Health of Fujian Key Universities, Fujian Medical University, Fujian, China.

Fengqiong Liu (F)

Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fujian, China.
Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Lin Cai (L)

Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fujian, China.
Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Zhijian Hu (Z)

Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fujian, China.
Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Baochang He (B)

Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fujian, China.
Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.
Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

Fa Chen (F)

Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fujian, China.
Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH